- Home
- DXC vs PRGO Comparison
DXC vs PRGO Comparison
Compare DXC & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DXC
- PRGO
- Stock Information
- Founded
- DXC 1959
- PRGO 1887
- Country
- DXC United States
- PRGO Ireland
- Employees
- DXC N/A
- PRGO N/A
- Industry
- DXC EDP Services
- PRGO Biotechnology: Pharmaceutical Preparations
- Sector
- DXC Technology
- PRGO Health Care
- Exchange
- DXC Nasdaq
- PRGO Nasdaq
- Market Cap
- DXC 3.6B
- PRGO 3.6B
- IPO Year
- DXC N/A
- PRGO 1991
- Fundamental
- Price
- DXC $20.78
- PRGO $26.81
- Analyst Decision
- DXC Hold
- PRGO Buy
- Analyst Count
- DXC 9
- PRGO 4
- Target Price
- DXC $20.89
- PRGO $37.00
- AVG Volume (30 Days)
- DXC 1.3M
- PRGO 1.9M
- Earning Date
- DXC 11-07-2024
- PRGO 11-06-2024
- Dividend Yield
- DXC N/A
- PRGO 4.12%
- EPS Growth
- DXC N/A
- PRGO N/A
- EPS
- DXC 0.13
- PRGO N/A
- Revenue
- DXC $13,262,000,000.00
- PRGO $4,392,000,000.00
- Revenue This Year
- DXC N/A
- PRGO N/A
- Revenue Next Year
- DXC N/A
- PRGO $4.51
- P/E Ratio
- DXC $163.36
- PRGO N/A
- Revenue Growth
- DXC N/A
- PRGO N/A
- 52 Week Low
- DXC $14.79
- PRGO $23.89
- 52 Week High
- DXC $25.14
- PRGO $34.60
- Technical
- Relative Strength Index (RSI)
- DXC 47.33
- PRGO 56.38
- Support Level
- DXC $19.77
- PRGO $26.33
- Resistance Level
- DXC $23.18
- PRGO $27.72
- Average True Range (ATR)
- DXC 0.98
- PRGO 0.80
- MACD
- DXC 0.05
- PRGO 0.13
- Stochastic Oscillator
- DXC 19.86
- PRGO 66.42
About DXC DXC Technology Company
DXC Technology Co is a vendor-independent IT services provider. The company's operating segment includes Global Business Services (GBS) and Global Infrastructure Services (GIS). It generates maximum revenue from the GIS segment. GIS offerings include Cloud and Security; IT Outsourcing and Modern Workplace. Geographically, it derives a majority of revenue from the Other Europe region.
About PRGO Perrigo Company plc
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.